Anti-inflammatory function of Alzheimer’s disease drugs revealed The mechanism in anti-Alzheimer’s disease medications that inhibits the production of a destructive, inflammation-causing protein in the mind has been revealed by researchers at the Hebrew university of Jerusalem. The extensive research team working on this project was headed by Prof. Raz Yirmiya of the Psychology Department at the Hebrew University, Dr propecia pris i sverige . Yehuda Pollak, a post-doctoral fellow in Prof. Tamir Ben-Hur of the Hebrew University Faculty of Medication.

This study demonstrates that virus-particular T cells show exceptional activity in a few patients with this tumor and this can lead to new remedies for nasopharyngeal carcinoma.’ A majority of the patients remain totally disease-free one or two years following the treatment. Two individuals had no response to the treatment. One patient’s malignancy progressed after the infusion, which needed the addition of chemotherapy. However, the individual experienced a partial remission, whereas previous chemotherapy treatments alone had had no effect. The tenth patient’s disease did not better or worsen, but remained steady after treatment.